In recent years, many clinical studies have been performed to compare outcomes of PIVCs that were changed routinely against those that were only changed when clinically indicated (presence of a complication, infection, device malfunction, etc.). With over 300 million PIVCs sold in the US every year, the economic and clinical outcomes of such a policy change could be vast (2).
There is no doubt that innovative adhesives have spurred advancements in wound care over the years. Intricate border designs and strong adhesive components allow devices to be secured and wounds to be dressed. But as these medical adhesives grew stronger, human skin remained the same, creating a problem for people with poor skin integrity.